CA2479116A1 - Ligands cibles - Google Patents
Ligands cibles Download PDFInfo
- Publication number
- CA2479116A1 CA2479116A1 CA002479116A CA2479116A CA2479116A1 CA 2479116 A1 CA2479116 A1 CA 2479116A1 CA 002479116 A CA002479116 A CA 002479116A CA 2479116 A CA2479116 A CA 2479116A CA 2479116 A1 CA2479116 A1 CA 2479116A1
- Authority
- CA
- Canada
- Prior art keywords
- ligand
- moiety
- target
- affinity
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Publié sans précis
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002479116A CA2479116A1 (fr) | 2001-03-09 | 2002-03-11 | Ligands cibles |
Applications Claiming Priority (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27421701P | 2001-03-09 | 2001-03-09 | |
| US60/274,217 | 2001-03-09 | ||
| US27691101P | 2001-03-20 | 2001-03-20 | |
| US60/276,911 | 2001-03-20 | ||
| US27913201P | 2001-03-28 | 2001-03-28 | |
| US60/279,132 | 2001-03-28 | ||
| US60/281,029 | 2001-04-04 | ||
| US28102901P | 2001-04-07 | 2001-04-07 | |
| US30614801P | 2001-07-19 | 2001-07-19 | |
| US60/306,148 | 2001-07-19 | ||
| CA2368708 | 2002-01-14 | ||
| CA2,368,708 | 2002-01-14 | ||
| CA002479116A CA2479116A1 (fr) | 2001-03-09 | 2002-03-11 | Ligands cibles |
| PCT/CA2002/000317 WO2002072141A2 (fr) | 2001-03-09 | 2002-03-11 | Ligands cibles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2479116A1 true CA2479116A1 (fr) | 2002-09-19 |
Family
ID=34069479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002479116A Abandoned CA2479116A1 (fr) | 2001-03-09 | 2002-03-11 | Ligands cibles |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2479116A1 (fr) |
-
2002
- 2002-03-11 CA CA002479116A patent/CA2479116A1/fr not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090104195A1 (en) | Targeted ligands | |
| US20050069549A1 (en) | Targeted ligands | |
| US20050142539A1 (en) | Targeted ligands | |
| JP7256348B2 (ja) | Ｃｔｌａ４に対する単一ドメイン抗体及びその誘導タンパク質 | |
| Labrijn et al. | Bispecific antibodies: a mechanistic review of the pipeline | |
| JP6929951B2 (ja) | 抗ｌａｇ−３抗体およびその使用 | |
| JP7132232B2 (ja) | Ｃｄ１３７及び腫瘍抗原に結合できる二重特異性結合分子並びにその使用 | |
| JP7164544B2 (ja) | 制約されたｃｄ３結合を有する多重特異性ポリペプチド構築物およびそれを使用する方法 | |
| EP3268037B1 (fr) | Agonistes cd27 | |
| US11091546B2 (en) | Optimized PNE-based chimeric receptor T cell switches and uses thereof | |
| CN112789294A (zh) | 含有受限cd3结合结构域和受体结合区的多特异性多肽构建体及其使用方法 | |
| JP7466459B2 (ja) | 抗ｃｄ２７および抗ｐｄ－ｌ１抗体ならびに二重特異性構築物 | |
| CA2927543A1 (fr) | Commutateurs de cellules t a recepteur d'antigene chimere peptidique et leurs utilisations | |
| JP2019523651A (ja) | 抗ｐｓｍａ抗体およびその使用 | |
| EP3774921A1 (fr) | Domaines variables d'anticorps ciblant les dll3, et leur utilisation | |
| CA2414148A1 (fr) | Ligands cibles | |
| JP2021501575A (ja) | 二重特異性抗体並びにその製造方法及び使用方法 | |
| CA2513287A1 (fr) | Ligands cibles | |
| CA2402930A1 (fr) | Ligands cibles | |
| CA2479116A1 (fr) | Ligands cibles | |
| CA2441653A1 (fr) | Ligands cibles | |
| CA2397169A1 (fr) | Ligands cibles | |
| JP2021509275A (ja) | 抗ｃｄ４０抗体およびその使用 | |
| CA2357529A1 (fr) | Ligand polyvalent | |
| CA2365636A1 (fr) | Ligand multifonctionnel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20131209 |